Phosphatase-1 inhibitor-1 in physiological and pathological -adrenoceptor signalling
Authors:
Open Access
- 24 February 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 91 (3) , 392-401
Abstract
Control of protein phosphorylation–dephosphorylation events occurs through regulation of protein kinases and phosphatases. Phosphatase type 1 (PP-1) provides the main activity of serine/threonine protein phosphatases in the heart. Inhibitor-1 (I-1) was the first endogenous molecule found to inhibit PP-1 specifically. Notably, I-1 is activated by cAMP-dependent protein kinase A (PKA), and the subsequent prevention of target dephosphorylation by PP-1 provides distal amplification of β-adrenoceptor (β-AR) signalling. I-1 was found to be down-regulated and hypo-phosphorylated in human and experimental heart failure but hyperactive in human atrial fibrillation, implicating I-1 in the pathogenesis of heart failure and arrhythmias. Consequently, the therapeutic potential of I-1 in heart failure and arrhythmias has recently been addressed by the generation and analysis of several I-1 genetic mouse models. This review summarizes and discusses these data, highlights partially controversial issues on whether I-1 should be therapeutically reinforced or inhibited and suggests future directions to better understand the functional role of I-1 in physiological and pathological β-AR signalling.Keywords
This publication has 98 references indexed in Scilit:
- Ryanodine Receptor Phosphorylation by Calcium/Calmodulin-Dependent Protein Kinase II Promotes Life-Threatening Ventricular Arrhythmias in Mice With Heart FailureCirculation, 2010
- The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implicationsCardiovascular Research, 2010
- Phosphatase-1-inhibitor-1: amplifier or attenuator of catecholaminergic stress?Basic Research in Cardiology, 2010
- Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosisBasic Research in Cardiology, 2010
- β-Adrenergic receptor signaling in the heart: Role of CaMKIIJournal of Molecular and Cellular Cardiology, 2010
- Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiologyJournal of Molecular and Cellular Cardiology, 2009
- Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion InjuryCirculation Research, 2009
- From Promiscuity to Precision: Protein Phosphatases Get a MakeoverMolecular Cell, 2009
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)European Heart Journal, 2008
- Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1The EMBO Journal, 1997